In-Vitro Gametogenesis (IVG) for Oocyte Development
Medical Infertility (e.g., Premature Ovarian Insufficiency, age-related decline)
Key Facts
About Conception
Conception is a private, pre-revenue biotech pioneering in-vitro gametogenesis (IVG) to generate human eggs from stem cells. Its platform integrates developmental biology, 3D organoid engineering, and computational automation to recreate the complex process of egg development in the lab. The company is targeting significant unmet needs in fertility, including age-related decline in egg quality and quantity, as well as medical infertility, positioning itself at the forefront of a potentially transformative reproductive technology. Conception is in the pre-clinical research and development stage, building its platform and advancing towards a future clinical therapy.
View full company profile